Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and activity of the investigational drug
known as carfilzomib in the treatment of multiple myeloma (MM) when it is given at doses
above the usual dose after the standard dosing has become ineffective. The other purpose of
this study is to understand what causes the multiple myeloma to become resistant to
carfilzomib and whether this can be overcome in the laboratory.